Phase 1 study of Colorectal cancer vaccine in colorectal cancer patients
Latest Information Update: 07 Dec 2016
At a glance
- Drugs Ad5.F35 hGCC PADRE (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- 07 Dec 2016 New trial record
- 22 Nov 2016 According to a Viral Gene media release, this trial was successfully completed over a two-year period that concluded in 2015.